Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

APRI sales grew by 31% in 9 months

10/11/24 APRI

Ozon Pharmaceuticals began collecting applications for participation in the IPO

10/11/24 OZPH

APRI developer Sergey Shal has been appointed head of the company

10/11/24 APRI

Positive Technologies enters the data protection market

10/10/24 POSI

Fesco launched a regular container train from China to Russia

10/10/24 FESH

Henderson's revenues rose 13% in September

10/10/24 HNFG

Yandex launched a mobile application Alice

10/10/24 YDEX

Investment in the development of the Kolmozerskoye field will amount to ₽91 billion

10/10/24 GMKN

VTB does not plan to buy back its shares from non-residents

10/10/24 VTBR

T-Bank acquired 6.15% of Eurotrans

10/10/24 EUTR